Morgan Stanley’s Iovance Biotherapeutics IOVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $11.1M | Buy |
|
|||||
|
2025
Q1 | $13.4M | Buy |
|
|||||
|
2024
Q4 | $29.3M | Buy |
|
|||||
|
2024
Q3 | $20.2M | Sell |
|
|||||
|
2024
Q2 | $22.6M | Buy |
|
|||||
|
2024
Q1 | $39.9M | Sell |
|
|||||
|
2023
Q4 | $60.4M | Buy |
|
|||||
|
2023
Q3 | $11.3M | Sell |
|
|||||
|
2023
Q2 | $24.6M | Sell |
|
|||||
|
2023
Q1 | $47M | Buy |
|
|||||
|
2022
Q4 | $31.8M | Buy |
|
|||||
|
2022
Q3 | $10M | Sell |
|
|||||
|
2022
Q2 | $16M | Buy |
|
|||||
|
2022
Q1 | $9.3M | Buy |
|
|||||
|
2021
Q4 | $4.84M | Sell |
|
|||||
|
2021
Q3 | $7.86M | Buy |
|
|||||
|
2021
Q2 | $6.24M | Sell |
|
|||||
|
2021
Q1 | $17.5M | Buy |
|
|||||
|
2020
Q4 | $8.8M | Buy |
|
|||||
|
2020
Q3 | $3.56M | Sell |
|
|||||
|
2020
Q2 | $4.23M | Buy |
|
|||||
|
2020
Q1 | $3.02M | Sell |
|
|||||
|
2019
Q4 | $5.23M | Sell |
|
|||||
|
2019
Q3 | $5.34M | Buy |
|
|||||
|
2019
Q2 | $915K | Sell |
|
|||||
|
2019
Q1 | $870K | Sell |
|
|||||
|
2018
Q4 | $1.99M | Buy |
|
|||||
|
2018
Q3 | $1.69M | Sell |
|
|||||
|
2018
Q2 | $3.43M | Buy |
|
|||||
|
2018
Q1 | $2.7M | Buy |
|
|||||
|
2017
Q4 | $1.01M | Buy |
|
|||||
|
2017
Q3 | $666K | Buy |
|
|||||
|
2017
Q2 | $373K | Sell |
|
|||||
|
2017
Q1 | $624K | Sell |
|
|||||
|
2016
Q4 | $1.23M | Buy |
|
|||||
|
2016
Q3 | $234K | Sell |
|
|||||
|
2016
Q2 | $462K | Sell |
|
|||||
|
2016
Q1 | $336K | Buy |
|
|||||
|
2015
Q4 | $483K | Buy |
|
|||||
|
2015
Q3 | $238K | Buy |
|
|||||
|
2015
Q2 | $128K | Buy |
|
|||||
|
2015
Q1 | $164K | Buy |
|